<VariationArchive VariationID="570608" VariationName="NM_032806.6(POMGNT2):c.1232del (p.Gln411fs)" VariationType="Deletion" Accession="VCV000570608" Version="6" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-03-05" DateCreated="2018-10-10" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="561575" VariationID="570608">
      <GeneList>
        <Gene Symbol="POMGNT2" FullName="protein O-linked mannose N-acetylglucosaminyltransferase 2 (beta 1,4-)" GeneID="84892" HGNC_ID="HGNC:25902" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>3p22.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="43079234" stop="43106079" display_start="43079234" display_stop="43106079" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="43120720" stop="43147574" display_start="43120720" display_stop="43147574" Strand="-" />
          </Location>
          <OMIM>614828</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_032806.6(POMGNT2):c.1232del (p.Gln411fs)</Name>
      <CanonicalSPDI>NC_000003.12:43080199:T:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>3p22.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="43080200" stop="43080200" display_start="43080200" display_stop="43080200" variantLength="1" positionVCF="43080199" referenceAlleleVCF="CT" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="43121692" stop="43121692" display_start="43121692" display_stop="43121692" variantLength="1" positionVCF="43121691" referenceAlleleVCF="CT" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>Q411fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_706" sequenceAccession="LRG_706">
            <Expression>LRG_706:g.30884del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_706t1" sequenceAccession="LRG_706t1">
            <Expression>LRG_706t1:c.1232del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_706p1" sequenceAccession="LRG_706p1" change="p.Gln411fs">
            <Expression>LRG_706p1:p.Gln411fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.11" sequenceAccession="NC_000003" sequenceVersion="11" change="g.43121692del" Assembly="GRCh37">
            <Expression>NC_000003.11:g.43121692del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.12" sequenceAccession="NC_000003" sequenceVersion="12" change="g.43080200del" Assembly="GRCh38">
            <Expression>NC_000003.12:g.43080200del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_032930.1" sequenceAccession="NG_032930" sequenceVersion="1" change="g.30884del">
            <Expression>NG_032930.1:g.30884del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_032806.6" sequenceAccession="NM_032806" sequenceVersion="6" change="c.1232del" MANESelect="true">
            <Expression>NM_032806.6:c.1232del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_116195.2" sequenceAccession="NP_116195" sequenceVersion="2" change="p.Gln411fs">
            <Expression>NP_116195.2:p.Gln411fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="755487513" DB="dbSNP" />
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00000" Source="The Genome Aggregation Database (gnomAD), exomes" />
        <AlleleFrequency Value="0.00001" Source="Exome Aggregation Consortium (ExAC)" />
        <AlleleFrequency Value="0.00001" Source="Trans-Omics for Precision Medicine (TOPMed)" />
        <AlleleFrequency Value="0.00002" Source="The Genome Aggregation Database (gnomAD)" />
        <AlleleFrequency Value="0.00008" Source="NHLBI Exome Sequencing Project (ESP) Exome Variant Server" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_032806.6(POMGNT2):c.1232del (p.Gln411fs) AND Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 8" Accession="RCV000691508" Version="5">
        <ClassifiedConditionList TraitSetID="8884">
          <ClassifiedCondition DB="MedGen" ID="C3553813">Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 8</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-05-15" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-05-15" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2018-10-10" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <DescriptionHistory Dated="2023-02-02">
          <Description>Uncertain significance</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="8884" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17372" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, GTDC2-RELATED</ElementValue>
                <XRef Type="MIM" ID="614830" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 8</ElementValue>
                <XRef ID="MONDO:0013904" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MDDGA8</ElementValue>
                <XRef Type="MIM" ID="614830" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15846" />
                <XRef ID="15846" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="899" DB="Orphanet" />
              <XRef ID="C3553813" DB="MedGen" />
              <XRef ID="MONDO:0013904" DB="MONDO" />
              <XRef Type="MIM" ID="614830" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1591537" SubmissionDate="2024-02-07" DateLastUpdated="2024-02-28" DateCreated="2018-10-10">
        <ClinVarSubmissionID localKey="1001432|MedGen:C3553813" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000819291" DateUpdated="2024-02-28" DateCreated="2018-10-10" Type="SCV" Version="6" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-05-15">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the POMGNT2 protein in which other variant(s) (p.Glu519*) have been determined to be pathogenic (Invitae). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. ClinVar contains an entry for this variant (Variation ID: 570608). This premature translational stop signal has been observed in individual(s) with clinical features of Walker-Warburg syndrome (Invitae). This variant is present in population databases (rs755487513, gnomAD 0.0009%). This sequence change creates a premature translational stop signal (p.Gln411Argfs*55) in the POMGNT2 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 170 amino acid(s) of the POMGNT2 protein.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="POMGNT2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000003.11:g.43121692del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C3553813" Type="CUI" />
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">28492532</ID>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB12506961</SubmissionName>
          <SubmissionName>SUB14200269</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1591537" TraitType="Disease" MappingType="XRef" MappingValue="C3553813" MappingRef="MedGen">
        <MedGen CUI="C3553813" Name="Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 8" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

